Co-founder and President of Beijing Genome Institute (BGI), Dr. Wang Jian, along with Dr. Yu Hao , supervisor of the BGI group Board Office visited the SUSTech Department of Biomedical Engineering (BME SUSTech) on the 7th of December evening. Assoc. Professor Chen Fangyi, Assoc. Professor Likai, Asst. Professor Guo Qiongyu, Asst. Professor Ho Chun Loong, Asst. Professor Liu Chao and Miss Deng Dandan were in attendance to welcome the BGI entourage, aiming to foster closer collaborative ties through the many research projects that are ongoing in the various laboratories.
President Wang highlighted the various potential collaborative work in multi-omic analysis with key foci on proteomic, metagenomic, and transcriptomic analysis. The multi-omic research provides tools to help further propel the development and later commercialization of the technologies established in BME SUSTech. President Wang emphasized his intent to further contribute to the Pearl Delta region's growth and research advancement through closer collaboration with SUSTech. Preliminary discussions include many key research work within the department's main research areas, including mechanomedicine, multiscale/multimodal biomedical imaging, wearable devices and wireless monitoring, biomedical MEMS, de novo regenerative engineering, computational medicine for big data, and health informatics. This BGI-BME SUSTech visit embodies both parties' commitment to the continual collaboration to thrust the technological development and nurturing of specialized-trained workforce within the region.
The BGI-BME SUSTech visit. (from left to right: Assoc. Professor Likai, Asst. Professor Guo Qiongyu, President Wang Jian, Asst. Professor Liu Chao, Assoc. Professor Chen Fangyi, Asst. Professor Ho Chun Loong)
President Wang Jian (second from the right) and Dr. Yu Hao (center) explaining BGI’s latest technological advancement to the members of SUSTech BME.
Asst. Professor Ho Chun Loong explaining his research work to President Wang Jian and Dr. Yu Hao during their visit to his laboratory.
Reported by DENG Dandan
SUSTech Kai Li’s team makes progress in type-I photosensitizers with tumor-associated macrophages polarizing activity